Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00306943 | Annual Study for Fluarix Registration | PHASE3 | COMPLETED | 120 | — | — | Jul 1, 2005 | Aug 1, 2005 | Sep 21, 2016 | 5 | Germany |
| Name | Type | Description |
|---|---|---|
| Influsplit SSW® | BIOLOGICAL | - |
Inclusion Criteria: * Subjects who the investigator believes that they can and will comply with the requirements of the protocol (e.g. completion of the diary cards, return, and follow-up visits) should be enrolled in the study. * All Subjects, enrolled in this study, must not been immunized agains...